Explorer

Covaxin Neutralises Corona Mutant: ICMR Study Shows Covid Vaccine Effective Against Multiple Variants

ICMR study shows COVAXIN neutralises against multiple variants of SARS-CoV-2 and effectively neutralises the double mutant strain as well. 

In a major breakthrouh for India amid the long going battle against novel Coronavirus, a study conducted by Indian Council of Medical Research (ICMR) shows Indigenous Covid-19 vaccine COVAXIN, made by Bharat Biotech, neutralises against multiple variants of SARS-CoV-2 and effectively neutralises the double mutant strain as well. 

ICMR in a statement on Wednesday said, "ICMR study shows COVAXIN neutralises against multiple variants of SARS-CoV-2 and effectively neutralises the double mutant strain as well."

ALSO READ | Covishield Vaccine Price: Serum Institute Fixes Price For State Govt & Private Hospitals

<blockquote class="twitter-tweet" data-partner="tweetdeck"><p lang="en" dir="ltr">ICMR study shows COVAXIN neutralises against multiple variants of SARS-CoV-2 and effectively neutralises the double mutant strain as well: Indian Council of Medical Research (ICMR) <a href="https://twitter.com/hashtag/COVID19?src=hash&amp;ref_src=twsrc%5Etfw" rel='nofollow'>#COVID19</a> <a href="https://t.co/QDM6UcaJkg" rel='nofollow'>pic.twitter.com/QDM6UcaJkg</a></p>&mdash; ANI (@ANI) <a href="https://twitter.com/ANI/status/1384765208279666693?ref_src=twsrc%5Etfw" rel='nofollow'>April 21, 2021</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script> 

Covaxin has received Emergency Use Authorizations (EUAs) for COVID-19 treatment in India and in several countries across the globe. 

Earlier this month, the Centre said the current production capacity of indigenously developed Covaxin vaccine will be doubled by May-June and then increased nearly six to seven fold by July - August, adding it is expected to reach nearly 10 crore doses per month by September.

Union Finance Minister Nirmala Sitharaman had recently approved Rs 4,567.50 crore advance amount to Serum Institute of India (SII) and Bharat Biotech to ramp up vaccine production against coronavirus.

ALSO READ | Study Published In Lancet Says Covaxin Made By Bharat Biotech Safe To Use; But Needs Phase 3 Results To Assess Efficacy

Check out below Health Tools-
Calculate Your Body Mass Index ( BMI )

Calculate The Age Through Age Calculator

View More
Advertisement
Advertisement
25°C
New Delhi
Rain: 100mm
Humidity: 97%
Wind: WNW 47km/h
See Today's Weather
powered by
Accu Weather
Advertisement

Top Headline

Kejriwal To Stay Delhi CM From Jail As High Court Finds 'No Legal Bar,' Ball In LG's Court Now
Kejriwal To Stay Delhi CM From Jail As High Court Finds 'No Legal Bar,' Ball In LG's Court Now
PM Modi Calls Congress A 'Bully' After Lawyers Write To CJI. Here's What He Said
PM Modi Calls Congress A 'Bully' After Lawyers Write To CJI. Here's What He Said
Roof Collapses During Renovation Work At Chennai Bar, 3 Dead
Roof Collapses During Renovation Work At Chennai Bar, 3 Dead
Arvind Kejriwal To Stay In ED Custody For 3 More Days — A Timeline Of Delhi CM's Battle In Courts
Arvind Kejriwal To Stay In ED Custody For 3 More Days — A Timeline Of Delhi CM's Battle In Courts
Advertisement
for smartphones
and tablets

Videos

Elvish Yadav's reaction on Munawar Faruqui's arrest, Watch Video | HOT NewsNawazuddin Siddiqui And Aliya Fixes Relationship Disbalance For Kids Upbringing | Khabar Filmy HaiRamayana: Sakshi Tanwar dismisses speculations of being a part of the movie, Watch videoWill there be a date clash between Bigg Boss 18 and Lock Up Season 2? | HOT News

Photogallery

Embed widget